Resveratrol Inhibits MMP3 and MMP9 Expression and Secretion by Suppressing TLR4/NF-κB/STAT3 Activation in Ox-LDL-Treated HUVECs
Open Access
- 10 September 2019
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-15
Abstract
Aim. Resveratrol is a natural plant polyphenol. The present study investigated the effects of resveratrol on the Toll-like receptor 4- (TLR4-) mediated expression and secretion of matrix metalloproteinases (MMPs) in oxidized low-density lipoprotein- (ox-LDL-) treated human umbilical vein endothelial cells (HUVECs). Methods. Protein expression was analyzed by immunoblotting. The secretion of MMPs was measured by an enzyme-linked immunosorbent assay. The animal experiments were performed with and without resveratrol treatment in high-fat chow-fed mice. Results. Resveratrol inhibited the expression of TLR4, MMP3, and MMP9 in ox-LDL- and lipopolysaccharide- (LPS-) treated HUVECs. Resveratrol reduced the secretion of MMP3 and MMP9 that was induced by ox-LDL and LPS. The TLR4 inhibitor CLI-095 similarly suppressed the expression and secretion of MMP3 and MMP9 in ox-LDL- and LPS-treated HUVECs. Resveratrol attenuated the phosphorylation of the transcription factors nuclear factor-κB (NF-κB) and signal transducer and activator of transcription 3 (STAT3) that was induced by ox-LDL and LPS. Resveratrol recovered Sirt1 expression. In the animal experiments, resveratrol decreased TLR4 expression in the aorta, MMP9 levels in plasma, and vascular structural changes in high-fat chow-fed mice, with no significant effect on plasma MMP3 levels. Conclusion. Resveratrol inhibited the TLR4-mediated expression and secretion of MMP3 and MMP9 in ox-LDL-treated HUVECs. The mechanism of action of resveratrol may be associated with the suppression of NF-κB and STAT3 phosphorylation and restoration of Sirt1 expression. Resveratrol exerts protective effects against vascular structural changes in high-fat chow-fed mice.Keywords
Funding Information
- National Natural Science Foundation of China (81070231, 81270379, 81471051, 91649110)
- National Natural Science Foundation of China (81070231, 81270379, 81471051, 91649110)
- National Natural Science Foundation of China (81070231, 81270379, 81471051, 91649110)
- National Natural Science Foundation of China (81070231, 81270379, 81471051, 91649110)
This publication has 43 references indexed in Scilit:
- Oxidative Stress-Mediated Atherosclerosis: Mechanisms and TherapiesFrontiers in Physiology, 2017
- Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditionsBlood, 2017
- Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular MedicineCurrent Pharmaceutical Design, 2016
- Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targetsCytokine & Growth Factor Reviews, 2015
- Ginkgolide B Inhibits JAM-A, Cx43, and VE-Cadherin Expression and Reduces Monocyte Transmigration in Oxidized LDL-Stimulated Human Umbilical Vein Endothelial CellsOxidative Medicine and Cellular Longevity, 2015
- Inflammation and Atherosclerosis—RevisitedJournal of Cardiovascular Pharmacology and Therapeutics, 2013
- Toll-Like Receptors in AtherosclerosisInternational Journal of Molecular Sciences, 2013
- Thematic Review Series: The Immune System and Atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular diseaseJournal of Lipid Research, 2005
- Endotoxin-Induced Maturation of MyD88-Deficient Dendritic CellsThe Journal of Immunology, 2001
- Mitogenic effect of oxidized low‐density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathwayBritish Journal of Pharmacology, 2001